Abstract
A chromogenic medium for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile esculin azide agar with 6 μg/ml vancomycin (BEAV) for the isolation of vancomycin-resistant enterococci (VRE) from stool specimens. At 24 to 28 h, VRESelect demonstrated 98.7% (confidence interval [CI], 96.1 to 99.7%) sensitivity and 99.0% (CI, 98.0 to 99.6%) specificity versus 85.1% (CI, 79.8 to 89.5%) and 90.1% (CI, 79.8 to 89.5%) sensitivity and specificity, respectively, for BEAV.
| Original language | English |
|---|---|
| Pages (from-to) | 2758-2760 |
| Number of pages | 3 |
| Journal | Journal of clinical microbiology |
| Volume | 51 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2013 |
| Externally published | Yes |
Fingerprint Dive into the research topics of 'Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium'. Together they form a unique fingerprint.
Cite this
Anderson, N. W., Buchan, B. W., Young, C. L., Newton, D. W., Brenke, C., Lapsley, L., Granato, P. A., & Ledeboer, N. A. (2013). Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of clinical microbiology, 51(8), 2758-2760. https://doi.org/10.1128/JCM.00979-13